Rosenblatt Maintains Buy Rating on IMAX, Sets $65 Price Target
Rosenblatt maintained its Buy rating on IMAX and a $65 price target. The target implies 25.8% upside from the Oct. 13 close of $51.66.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.